Inventor
MARK LAURENCE BOYS
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes30%
PatentTitleYear
12,187,721Protein tyrosine phosphatase inhibitors202511,884,664Protein tyrosine phosphatase inhibitors202411,834,453Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors202311,802,1273,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors202311,691,9733,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors202311,634,417Protein tyrosine phosphatase inhibitors202311,247,990Bicyclic fused pyridine compounds as inhibitors of TAM kinases2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ARRAY BIOPHARMA INC (5)· patent assignee history
2022–2025Based in US· patent location history
2023Patents assigned to PFIZER (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARRAY BIOPHARMA INC | 5 | 2022–2025 |
| PFIZER | 2 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2025 |